COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > WHY NO INSIDER BUYER

<< Previous

Bullboard Posts

Next >>

Comment by Hopeforthebeston Aug 23, 2024 5:21pm

37 Views

Post# 36194107

RE:RE:RE:RE:RE:RE:RE:RE:WHY NO INSIDER BUYER

The only thing that a COMPETENT BUSINESS PERSON wanys to hear is ON TIME and ON BUDGET, the the dribble you/gagnon spout. Just unbelievable garbage from the biggest sanitation engineer there is

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)